🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
897 medicines starting with “A”
MedicineActive substanceLicence holderStatus
Atacand 8 mg tablets
PA2239/010/002
Candesartan cilexetil CHEPLAPHARM Arzneimittel GmbH Marketed
Atacand 8 mg tablets
PPA0465/116/001
Candesartan cilexetil PCO Manufacturing Ltd.
Atacand 8 mg tablets
PPA1463/031/001
Candesartan cilexetil IMED Healthcare Ltd.,
Atacand Plus 16 mg/12.5 mg tablets
PA2239/011/002
Candesartan cilexetil, Hydrochlorothiazide CHEPLAPHARM Arzneimittel GmbH Marketed
Atacand Plus 16 mg/12.5 mg tablets
PPA0465/117/001
Candesartan cilexetil, Hydrochlorothiazide PCO Manufacturing Ltd.
Atacand Plus 16 mg/12.5 mg tablets
PPA1463/053/001
Candesartan cilexetil, Hydrochlorothiazide IMED Healthcare Ltd.,
Atacand Plus 8 mg/12.5 mg tablets
PA2239/011/001
Candesartan cilexetil, Hydrochlorothiazide CHEPLAPHARM Arzneimittel GmbH Not marketed
Atazanavir Rowex 300 mg hard capsules
PA0711/287/004
Atazanavir sulfate Rowex Ltd Marketed
Atazanavir Viatris 150 mg hard capsules
EU/1/16/1091/001-003
Atazanavir sulfate Viatris Limited
Atazanavir Viatris 200 mg hard capsules
EU/1/16/1091/004-006
Atazanavir sulfate Viatris Limited
Atazanavir Viatris 200 mg hard capsules
EU/1/16/1091/007-010
Atazanavir sulfate Viatris Limited
Atecor 100mg Tablets
PA0711/003/003
Atenolol Rowex Limited, Marketed
Atecor 25mg Tablets
PA0711/003/001
Atenolol Rowex Limited, Marketed
Atecor 50mg Tablets
PA0711/003/002
Atenolol Rowex Limited, Marketed
Atecor CT 100 mg/25 mg Film-coated tablets
PA0711/020/002
Chlortalidone, Atenolol Rowex Limited, Marketed
Atecor CT 50 mg/12.5 mg Film-coated tablets
PA0711/020/001
Chlortalidone, Atenolol Rowex Limited, Marketed
Atectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsules
EU/1/20/1439/005-008
Indacaterol acetate, Mometasone furoate Novartis Europharm Limited
Atectura Breezhaler 125 micrograms/260 micrograms inhalation powder, hard capsules
EU/1/20/1439/009-012
Indacaterol acetate, Mometasone furoate Novartis Europharm Limited
Atectura Breezhaler 125 micrograms/62.5 micrograms inhalation powder, hard capsules
EU/1/20/1439/001-004
Indacaterol acetate, Mometasone furoate Novartis Europharm Limited
Atenomel 100 mg Tablets
PA0126/069/002
Atenolol Clonmel Healthcare Ltd Marketed
Atenomel 25 mg Tablets
PA0126/069/003
Atenolol Clonmel Healthcare Ltd Marketed
Atenomel 50 mg Tablets
PA0126/069/001
Atenolol Clonmel Healthcare Ltd Marketed
Atgam 50 mg/ml concentrate for solution for infusion
PA0822/238/001
Anti-T Lymphocyte Immunoglobulin for Human Use, Horse Pfizer Healthcare Ireland Unlimited Company Marketed
Ativan 1 mg Tablets
PA0822/090/001
Lorazepam Pfizer Healthcare Ireland Unlimited Company Marketed
Atomoxetine Accord 10 mg Hard Capsules
PA2315/019/001
Atomoxetine hydrochloride Accord Healthcare Ireland Ltd. Marketed
Atomoxetine Accord 100 mg Hard Capsules
PA2315/019/007
Atomoxetine hydrochloride Accord Healthcare Ireland Ltd. Marketed
Atomoxetine Accord 18 mg Hard Capsules
PA2315/019/002
Atomoxetine hydrochloride Accord Healthcare Ireland Ltd. Marketed
Atomoxetine Accord 25 mg Hard Capsules
PA2315/019/003
Atomoxetine hydrochloride Accord Healthcare Ireland Ltd. Marketed
Atomoxetine Accord 40 mg Hard Capsules
PA2315/019/004
Atomoxetine hydrochloride Accord Healthcare Ireland Ltd. Marketed
Atomoxetine Accord 60 mg hard capsules
PA2315/019/005
Atomoxetine hydrochloride Accord Healthcare Ireland Ltd. Marketed
Atomoxetine Accord 80 mg hard capsules
PA2315/019/006
Atomoxetine hydrochloride Accord Healthcare Ireland Ltd. Marketed
Atomoxetine Azure 10 mg hard capsules
PA22871/034/001
Atomoxetine hydrochloride Azure Pharmaceuticals Ltd. Not marketed
Atomoxetine Azure 100 mg hard capsules
PA22871/034/007
Atomoxetine hydrochloride Azure Pharmaceuticals Ltd. Not marketed
Atomoxetine Azure 18 mg hard capsules
PA22871/034/002
Atomoxetine hydrochloride Azure Pharmaceuticals Ltd. Not marketed
Atomoxetine Azure 25 mg hard capsules
PA22871/034/003
Atomoxetine hydrochloride Azure Pharmaceuticals Ltd. Not marketed
Atomoxetine Azure 40 mg hard capsules
PA22871/034/004
Atomoxetine hydrochloride Azure Pharmaceuticals Ltd. Not marketed
Atomoxetine Azure 60 mg hard capsules
PA22871/034/005
Atomoxetine hydrochloride Azure Pharmaceuticals Ltd. Not marketed
Atomoxetine Azure 80 mg hard capsules
PA22871/034/006
Atomoxetine hydrochloride Azure Pharmaceuticals Ltd. Not marketed
Atorvas 10 mg film-coated tablets
PA0711/180/001
Atorvastatin Rowex Limited, Marketed
Atorvas 20 mg film-coated tablets
PA0711/180/002
Atorvastatin Rowex Limited, Marketed
Atorvas 40 mg film-coated tablets
PA0711/180/003
Atorvastatin Rowex Limited, Marketed
Atorvas 80 mg film-coated tablets
PA0711/180/004
Atorvastatin Rowex Limited, Marketed
Atorvastatin 10 mg Film-coated tablets
PA2315/195/001
Atorvastatin Accord Healthcare Ireland Ltd. Marketed
Atorvastatin 10 mg Film-Coated Tablets
PA0281/236/001
Atorvastatin Pinewood Laboratories Limited Not marketed
Atorvastatin 10mg film-coated tablets
PA2050/003/001
Atorvastatin Sun Pharmaceutical Industries Europe B.V. Marketed
Atorvastatin 20 mg film-coated tablets
PA2050/003/002
Atorvastatin Sun Pharmaceutical Industries Europe B.V. Marketed
Atorvastatin 20 mg Film-coated tablets
PA2315/195/002
Atorvastatin Accord Healthcare Ireland Ltd. Marketed
Atorvastatin 20 mg Film-Coated Tablets
PA0281/236/002
Atorvastatin Pinewood Laboratories Limited Not marketed
Atorvastatin 40 mg film-coated tablets
PA2050/003/003
Atorvastatin Sun Pharmaceutical Industries Europe B.V. Marketed
Atorvastatin 40 mg Film-coated tablets
PA2315/195/003
Atorvastatin Accord Healthcare Ireland Ltd. Marketed
12 13 14 15 16 17 18
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.